| CAS NO: | 81586-39-2 |
| 包装 | 价格(元) |
| 100µg | 电议 |
| 1mg | 电议 |
| Cas No. | 81586-39-2 |
| 别名 | 6Α,7,8,10Α-四氢-6,6,9-三甲基-3-(戊基-5,5,5-D3)-6H-二苯并[B,D]吡喃-1-醇 |
| Canonical SMILES | CC1=C[C@@]2([C@@]([H])(CC1)C(C)(OC3=C2C(O)=CC(CCCCC([2H])([2H])[2H])=C3)C)[H] |
| 分子式 | C21H27D3O2 |
| 分子量 | 317.5 |
| 储存条件 | -20°C |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
| 产品描述 | δ9-THC-d3(CRM) is a certified reference material that is intended for use as an internal standard for the quantification of δ9-THC by GC- or LC-MS. δ9-THC is categorized as a cannabinoid.1,2It is psychoactive and has diverse effects on perception, cognition, and pain sensitivity.3δ9-THC-d3is regulated as a Schedule I compound in the United States. δ9-THC-d3(CRM) is provided as a DEA exempt preparation. This product is intended for research and forensic applications. 1.Huffman, J.W., Padgett, L.W., Isherwood, M.L., et al.1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles: New high affinity ligands for the cannabinoid CB1 and CB2 receptorsBioorg. Med. Chem. Lett.16(20)5432-5435(2006) 2.Pertwee, R.G.Pharmacology of cannabinoid receptor ligandsCurr. Med. Chem.6(8)635-664(1999) 3.Grotenhermen, F.Pharmacokinetics and pharmacodynamics of cannabinoidsClin. Pharmacokinet.42(4)327-360(2003) |
m.cnreagent.com